Neurogene Inc. NGNE | $51.12M | 7.74 | 1M | +1.01% | +$512,155.80 | 8.56 | |
| UroGen Pharma Ltd. URGN | $39.31M | 7.25 | 2.62M | 0% | +$0 | 6.59 | |
VistaGen Therapeutics, Inc. VTGN | $9.81M | 6.88 | 1.86M | 0% | +$0 | 1.64 | |
| Outlook Therapeutics, Inc. OTLK | $17.67M | 6.32 | 1.48M | New | +$17.67M | 2.96 | |
| OptiNose, Inc. OPTN | $12.83M | 6.07 | 8.79M | -0.61% | -$78,286.66 | 2.15 | |
Zura Bio Limited ZURA | $7.09M | 4.33 | 2.76M | -16.3% | -$1.38M | 1.19 | |
| Esperion Therapeutics, Inc. ESPR | $21.44M | 4.22 | 8M | New | +$21.44M | 3.59 | |
| Evolus, Inc. EOLS | $34.3M | 3.91 | 2.45M | +22.5% | +$6.3M | 5.75 | |
| AnaptysBio, Inc. ANAB | $22M | 3.58 | 976,981 | 0% | +$0 | 3.69 | |
| Aerovate Therapeutics, Inc. AVTE | $26.25M | 3.08 | 887,690 | -14.46% | -$4.44M | 4.4 | |
| Pliant Therapeutics, Inc. PLRX | $27.59M | 3.07 | 1.85M | +1.57% | +$427,332.01 | 4.62 | |
| Puma Biotechnology, Inc. PBYI | $7.12M | 2.79 | 1.34M | +22.9% | +$1.33M | 1.19 | |
Mind Medicine (MindMed) Inc. MNMD | $18.8M | 2.78 | 2M | New | +$18.8M | 3.15 | |
Jasper Therapeutics, Inc. JSPR | $11.97M | 2.7 | 407,550 | New | +$11.97M | 2.01 | |
Helix Acquisition Corp. II Class A Ordinary Shares HLXB | $5.2M | 2.17 | 500,000 | New | +$5.2M | 0.87 | |
Dianthus Therapeutics, Inc. DNTH | $18.75M | 2.13 | 625,000 | New | +$18.75M | 3.14 | |
| Viridian Therapeutics, Inc. VRDN | $23.38M | 2.09 | 1.33M | New | +$23.38M | 3.92 | |
| Terns Pharmaceuticals, Inc. TERN | $8.59M | 2.03 | 1.31M | 0% | +$0 | 1.44 | |
| Ocular Therapeutix, Inc. OCUL | $15.73M | 1.12 | 1.73M | +146.96% | +$9.36M | 2.64 | |
| Dynavax Technologies Corporation DVAX | $15.7M | 0.97 | 1.26M | New | +$15.7M | 2.63 | |
Apogee Therapeutics, Inc. APGE | $26.58M | 0.68 | 400,000 | 0% | +$0 | 4.45 | |
| Xenon Pharmaceuticals Inc. XENE | $19.64M | 0.6 | 456,148 | -23.98% | -$6.19M | 3.29 | |
| Arcellx, Inc. ACLX | $20.86M | 0.56 | 300,000 | +521.58% | +$17.51M | 3.5 | |
| Insmed Incorporated INSM | $21.04M | 0.52 | 775,585 | +243.31% | +$14.91M | 3.53 | |
| Amicus Therapeutics, Inc. FOLD | $17.62M | 0.51 | 1.5M | +16.79% | +$2.53M | 2.95 | |
Autolus Therapeutics plc AUTL | $7.44M | 0.44 | 1.17M | New | +$7.44M | 1.25 | |
| Merus N.V. MRUS | $10.05M | 0.38 | 223,288 | +1,016.44% | +$9.15M | 1.68 | |
Kyverna Therapeutics, Inc. Common Stock KYTX | $3.73M | 0.35 | 150,000 | New | +$3.73M | 0.62 | |
Spyre Therapeutics, Inc. SYRE | $4.74M | 0.31 | 125,000 | 0% | +$0 | 0.79 | |
Immunocore Holdings plc IMCR | $7.47M | 0.23 | 115,000 | -60.75% | -$11.57M | 1.25 | |
| Cytokinetics, Incorporated CYTK | $14.18M | 0.18 | 202,202 | -59.56% | -$20.88M | 2.38 | |
| Intra-Cellular Therapies, Inc. ITCI | $10.38M | 0.14 | 150,000 | +35.62% | +$2.73M | 1.74 | |
| Arvinas, Inc. ARVN | $2.94M | 0.1 | 71,113 | -69.62% | -$6.73M | 0.49 | |
Abivax SA American Depositary Shares ABVX | $35.59M | <0.01 | 2.49M | +60.55% | +$13.42M | 5.96 |